Suppr超能文献

人肝癌细胞系中低密度脂蛋白受体功能的调节

Regulation of low density lipoprotein receptor function in a human hepatoma cell line.

作者信息

Leichtner A M, Krieger M, Schwartz A L

出版信息

Hepatology. 1984 Sep-Oct;4(5):897-901. doi: 10.1002/hep.1840040518.

Abstract

Low density lipoprotein (LDL) processing was investigated in a human hepatoma-derived cell line, Hep G2. Hep G2 cells bound, internalized and degraded LDL via a saturable, high affinity (Kd approximately 2 X 10(-8)M) pathway similar to that present in other mammalian cells. Although 80% of the uptake and degradation of 125I-LDL was inhibited by 40-fold excess native LDL, the same concentration of methylated LDL, which cannot bind to LDL receptors, had virtually no effect on processing. When added at low concentrations, the lysosomotropic agent, chloroquine, inhibited degradation (I50 approximately 15 microM) without affecting the rate of lipoprotein internalization. Receptor activity was decreased 60% by preincubation of the cells in medium containing a source of cholesterol (LDL or unesterified cholesterol) and increased 1.7-fold by preincubation with compactin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. The Hep G2 cell line may prove a useful system both for the further study of hepatic lipoprotein metabolism and for the evaluation of new antihypercholesterolemic agents.

摘要

在源自人肝癌的细胞系Hep G2中研究了低密度脂蛋白(LDL)的代谢过程。Hep G2细胞通过一种可饱和的、高亲和力(解离常数Kd约为2×10⁻⁸M)途径结合、内化并降解LDL,该途径与其他哺乳动物细胞中的途径相似。虽然125I-LDL摄取和降解的80%被40倍过量的天然LDL抑制,但相同浓度的不能与LDL受体结合的甲基化LDL对代谢几乎没有影响。当以低浓度添加时,溶酶体促渗剂氯喹抑制降解(半数抑制浓度I50约为15微摩尔),而不影响脂蛋白内化速率。在含有胆固醇来源(LDL或未酯化胆固醇)的培养基中预孵育细胞可使受体活性降低60%,而用3-羟基-3-甲基戊二酰辅酶A还原酶的竞争性抑制剂美伐他汀预孵育可使受体活性增加1.7倍。Hep G2细胞系可能被证明是一个有用的系统,既用于进一步研究肝脏脂蛋白代谢,也用于评估新的抗高胆固醇血症药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验